Adma Biologics, Inc. (NASDAQ:ADMA) has 344 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 36,830,774 | 497,449 | 1.37% | $331,845,274.00 |
| State Street Corp | 31 Mar, 2026 | 14,084,205 | 486,946 | 3.58% | $126,898,687.00 |
| Capital Research Global Investors | 31 Mar, 2026 | 11,191,116 | 4,553,644 | 68.61% | $100,831,955.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 10,306,871 | 10,306,871 | 0.00% | $92,864,908.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 8,868,657 | 8,868,657 | 0.00% | $79,906,600.00 |
| Nuveen, LLC | 31 Mar, 2026 | 6,098,225 | 171,835 | 2.90% | $54,945,008.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,824,116 | -6,825 | -0.12% | $52,484,178.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 5,810,642 | 4,288,072 | 281.63% | $52,353,885.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 5,005,481 | 169,843 | 3.51% | $45,101,264.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Mar, 2026 | 4,789,011 | -409,368 | -7.87% | $43,148,996.00 |
| Caligan Partners LP | 31 Mar, 2026 | 4,756,511 | 1,744,003 | 57.89% | $42,856,164.00 |
| Invesco Ltd. | 31 Mar, 2026 | 4,119,577 | -7,665,625 | -65.04% | $37,117,389.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 3,997,675 | 2,071,338 | 107.53% | $36,019,052.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 3,434,449 | 2,764,778 | 412.86% | $30,944,385.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 3,288,757 | 2,894,878 | 734.97% | $29,631,701.00 |
| B Group, Inc. | 31 Mar, 2026 | 3,207,542 | 750,000 | 30.52% | $28,899,953.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 3,051,943 | 2,592,519 | 564.30% | $27,498,007.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 2,803,530 | 664,480 | 31.06% | $25,259,806.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,434,379 | 486,006 | 24.94% | $21,933,757.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 2,344,899 | -448,957 | -16.07% | $21,127,540.00 |